BlackRock Institutional Trust’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $13.2M | Buy |
2,079,497
+122,927
| +6% | +$778K | ﹤0.01% | 2234 |
|
|
2016
Q3 | $8.63M | Buy |
1,956,570
+102,535
| +6% | +$452K | ﹤0.01% | 2419 |
|
|
2016
Q2 | $5.27M | Sell |
1,854,035
-14,210
| -0.8% | -$40.4K | ﹤0.01% | 2653 |
|
|
2016
Q1 | $5.29M | Buy |
1,868,245
+62,930
| +3% | +$178K | ﹤0.01% | 2626 |
|
|
2015
Q4 | $18.6M | Buy |
1,805,315
+113,053
| +7% | +$1.17M | ﹤0.01% | 1921 |
|
|
2015
Q3 | $19.3M | Sell |
1,692,262
-131,691
| -7% | -$1.5M | ﹤0.01% | 1862 |
|
|
2015
Q2 | $27.2M | Sell |
1,823,953
-89,324
| -5% | -$1.33M | ﹤0.01% | 1706 |
|
|
2015
Q1 | $17.3M | Buy |
1,913,277
+473
| +0% | +$4.27K | ﹤0.01% | 2041 |
|
|
2014
Q4 | $23.3M | Sell |
1,912,804
-19,561
| -1% | -$238K | ﹤0.01% | 1804 |
|
|
2014
Q3 | $18.9M | Sell |
1,932,365
-12,476
| -0.6% | -$122K | ﹤0.01% | 1909 |
|
|
2014
Q2 | $24.8M | Buy |
1,944,841
+865,445
| +80% | +$11M | ﹤0.01% | 1806 |
|
|
2014
Q1 | $11.4M | Sell |
1,079,396
-52,256
| -5% | -$553K | ﹤0.01% | 2333 |
|
|
2013
Q4 | $8.6M | Sell |
1,131,652
-33,541
| -3% | -$255K | ﹤0.01% | 2504 |
|
|
2013
Q3 | $8.48M | Buy |
1,165,193
+10,492
| +0.9% | +$76.4K | ﹤0.01% | 2461 |
|
|
2013
Q2 | $1.79M | Buy |
+1,154,701
| New | +$1.79M | ﹤0.01% | 3139 |
|